Archive for December, 2009

Men of science have discovered a protein that could be involved in the growing of type 2 diabetes mellitus, a discovery that may lead to fresh medications to fight this developing worldwide scourge.

This same team of research workers recently demonstrated that inhibiting this nerve tract acted to block pain affiliated with gouty arthritis, an inflammatory case affecting the joints.

Inflaming also plays a scaled role in diabetes mellitus.

The writers of this research, released online December 21 in Nature Immunology, commenced their exploration with the NLRP3 inflammasome, which has been associated with dissimilar inflammatory disorders. Read the rest of this entry »



The Food and Drug Administration is regarding amplifying the use of cholesterin depressing statin Crestor to those who have multiplied rates of inflammation—just not high cholesterol. The authority acted one step nearer on Tuesday later on a consultative panel voted twelve to four (with one abstinence) to okay Crestor for this amplified use, which may open the door for 6.5 million more American People to take lipid-lowering medications.

Have lipid-lowering medicines substituted aspirin as the fresh wonder medication? Read the rest of this entry »